Mount Sinai Announces the Formation of Clinical-Stage Infectious Diseases Company CastleVax Industry News August 9, 2022 …
Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19 Public Health July 17, 2022 …
Adverse Events After Simultaneous COVID-19 mRNA Booster, Flu Vaccination Medical Countermeasures July 16, 2022 …
Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs Industry News June 20, 2022 …
Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit Health Security June 2, 2022 …
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors Industry News May 26, 2022 …
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools Biodetection May 6, 2022 …
BugSeq Awarded BARDA DRIVe Funding to Develop Next-Gen Diagnostics for Any Respiratory RNA Virus Health Security May 3, 2022 …
Troubling Trends in Physician Vaccine Confidence in the United States Medical Countermeasures April 5, 2022 …
Northwestern University Researchers Develop Nanoparticle Vaccine Platform Medical Countermeasures March 22, 2022 …
Will the BA.2 Subvariant Cause Another Wave of Infections in the US? Biosurveillance March 22, 2022 …
As New Zealand Relaxes Restrictions, Steps Can Still Be Taken to Limit COVID Infections Public Health March 22, 2022 …
Some PASC Patients May Experience Long-Lasting Airway Disease — Even if They Only Had Mild COVID-19 Infectious Diseases March 22, 2022 …